Stock listing

BIOGB Stock Price, News, Filings & Events — Biogaia Ab Class B

Selected listing: BIOGB · OMXSTO · SEK · SE

This page tracks Biogaia Ab Class B's BIOGB:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOGB:OMXSTO. BIOGB:OMXSTO is the stock-level entry point for investors researching Biogaia Ab Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biogaia Ab Class B is a public company listed on the Swedish market under the ticker BIOG B. The company has a market capitalization of approximately 1.22 billion SEK. Biogaia focuses on the development and commercialization of probiotics and related products.

BIOGB:OMXSTOSEKSEUpdated August 22, 2026
Biogaia Ab Class B logo
Ticker
BIOG_B:OMXSTO
Asset type
Stock
Market cap
$1.22B
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
OMXSTO
Currency
SEK

Biogaia Ab Class B BIOGB:OMXSTO stock context

This page tracks Biogaia Ab Class B's BIOGB:OMXSTO listing on OMXSTO in SEK for SE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BIOGB:OMXSTO. BIOGB:OMXSTO is the stock-level entry point for investors researching Biogaia Ab Class B, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Biogaia Ab Class B is a public company listed on the Swedish market under the ticker BIOG B. The company has a market capitalization of approximately 1.22 billion SEK. Biogaia focuses on the development and commercialization of probiotics and related products.

Latest news from Biogaia Ab Class B

All Biogaia Ab Class B news →

Biogaia Ab Class B earnings calls

Research Biogaia Ab Class B

Alternate listings